Article
Protective KIR-HLA interactions for HCV infection in intravenous drug users.
Molecular immunology - 1 Aug 2009
Zúñiga Joaquín, Romero Viviana, Azocar José, Terreros Daniel, Vargas-Rojas María Inés, Torres-García Diana, Jiménez-Alvarez Luis, Vargas-Alarcón Gilberto, Granados-Montiel Julio, Husain Zaheed, Chung Raymond T, Alper Chester A, Yunis Edmond J
Abstract excerpt
Intravenous drug use has become the principal route of hepatitis C virus (HCV) transmission due to the sharing of infected needles. In this study, we analyzed the distribution of HLA-KIR genotypes among 160 Puerto Rican intravenous drug users (IDUs) with HCV infection and 92 HCV-negative Puerto Rican IDUs. We found a significant association between the presence of different combinations of KIR inhibitory receptor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
